A novel protocol for haploidentical hematopoietic SCT without in vitro T-cell depletion in the treatment of severe acquired aplastic anemia

[1]  W. Han,et al.  The inferiority of G-PB to rhG-CSF-mobilized blood and marrow grafts as a stem cell source in patients with high-risk acute leukemia who underwent unmanipulated HLA-mismatched/haploidentical transplantation: a comparative analysis , 2010, Bone Marrow Transplantation.

[2]  Yu-Hong Chen,et al.  [A clinical analysis of HLA-identical hematopoietic stem cell transplantation for severe aplastic anemia.]. , 2009, Zhonghua nei ke za zhi.

[3]  Yu-Hong Chen,et al.  Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation. , 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[4]  M. Führer,et al.  Risk-adapted procedures for HSCT from alternative donor in children with severe aplastic anaemia , 2008, Bone Marrow Transplantation.

[5]  Q. Jiang,et al.  Haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for treatment of hematological malignancies in children. , 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[6]  Wei Han,et al.  Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological malignancies , 2006, Bone Marrow Transplantation.

[7]  H. Schrezenmeier,et al.  Bone marrow transplants from mismatched related and unrelated donors for severe aplastic anemia , 2006, Bone Marrow Transplantation.

[8]  F. Locatelli,et al.  Fludarabine, cyclophosphamide and anti-thymocyte globulin for alternative donor transplants in acquired severe aplastic anemia: a report from the EBMT-SAA Working Party , 2005, Bone Marrow Transplantation.

[9]  J. Cunningham,et al.  Effective donor lymphohematopoietic reconstitution after haploidentical CD34+-selected hematopoietic stem cell transplantation in children with refractory severe aplastic anemia , 2004, Bone Marrow Transplantation.

[10]  Ling Zhu,et al.  [Clinical study on hematopoietic reconstitution in patients with leukemia by haploidentical bone marrow transplantation]. , 2003, Zhongguo shi yan xue ye xue za zhi.

[11]  G. Vassiliou,et al.  Improved outcome of alternative donor bone marrow transplantation in children with severe aplastic anaemia using a conditioning regimen containing low‐dose total body irradiation, cyclophosphamide and Campath , 2001, British journal of haematology.

[12]  C. Tzeng,et al.  CY/TBI-800 as a pretransplant regimen for allogeneic bone marrow transplantation for severe aplastic anemia using HLA-haploidentical family donors. , 1996, Bone marrow transplantation.

[13]  H. Deeg,et al.  Bone marrow transplantation for severe aplastic anemia from genotypically HLA-nonidentical relatives. An update of the Seattle experience. , 1996, Transplantation.

[14]  E. Gluckman,et al.  Bone marrow transplantation for severe aplastic anemia from donors other than HLA identical siblings: a report of the BMT Working Party. , 1988, Bone marrow transplantation.

[15]  H. Deeg,et al.  FAILURE OF ALLOGENEIC CANINE MARROW GRAFTS AFTER TOTAL‐BODY IRRADIATION: ALLOGENEIC “RESISTANCE” VERSUS TRANSFUSION‐INDUCED SENSITIZATION , 1986, Transplantation.

[16]  H. Deeg,et al.  Marrow transplantation for severe aplastic anemia: methotrexate alone compared with a combination of methotrexate and cyclosporine for prevention of acute graft-versus-host disease. , 1986, Blood.

[17]  H. Deeg,et al.  Marrow transplantation for severe aplastic anemia. Long-term outcome in fifty "untransfused" patients. , 1986, Annals of internal medicine.

[18]  H. Deeg,et al.  Marrow Transplantation in Thirty "Untransfused" Patients with Severe Aplastic Anemia , 1980, Annals of Internal Medicine.

[19]  R. Storb,et al.  Severe aplastic anemia: a prospective study of the effect of early marrow transplantation on acute mortality. , 1976, Blood.

[20]  S. Lee,et al.  Feasibility of NIH consensus criteria for chronic graft-versus-host disease , 2009, Leukemia.

[21]  J. Mehta,et al.  Addition of low-dose busulfan to cyclophosphamide in aplastic anemia patients prior to allogeneic bone marrow transplantation to reduce rejection , 2004, Bone Marrow Transplantation.

[22]  K. Chik,et al.  A fludarabine-based conditioning regimen for severe aplastic anemia , 2001, Bone Marrow Transplantation.

[23]  R. Brand,et al.  Treatment of acquired severe aplastic anemia: bone marrow transplantation compared with immunosuppressive therapy--The European Group for Blood and Marrow Transplantation experience. , 2000, Seminars in hematology.

[24]  E. Gluckman,et al.  Bone marrow transplantation (BMT) in children with severe aplastic anemia (SAA) from donors other than HLA identical siblings. EBMT Working Party on Severe Aplastic Anemia. , 1991, Bone marrow transplantation.

[25]  D. Frappaz,et al.  The role of BMT for neuroblastoma relapse patients. A report of the EBMT-STR. , 1991, Bone marrow transplantation.